Communicable
By CMI Communications
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by CMI Communications
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 11
Reviews: 0
Episodes: 56
Description
Communicable takes on hot topics in infectious diseases and clinical microbiology. Hosted by the editors of CMI Communications, the open-access journal of ESCMID, the European Society of Clinical Microbiology & Infectious Diseases.
| Episode | Date |
|---|---|
|
Communicable E55: Bonus episode – Bundibugyo ebolavirus outbreak
|
Jun 07, 2026 |
|
Communicable E54: ESCMID Global Late Breakers, part 2
|
May 31, 2026 |
|
Communicable E53: ESCMID Global Late Breakers, part 1
|
May 17, 2026 |
|
Communicable E52: ESCMID Global Trials, PETER PEN and ASTARTE
|
May 08, 2026 |
|
A message to listeners, 4 May 2026
|
May 03, 2026 |
|
Communicable E51: We will make you love PK/PD, part 1
|
Apr 19, 2026 |
|
Communicable E50: Quarterly catch-up (April 2026 edition)
|
Apr 05, 2026 |
|
Communicable E49: Outbreaks & how to handle them
|
Mar 22, 2026 |
|
Communicable E48: International Women's Day - are infections & AMR really different in women?
|
Mar 08, 2026 |
|
Communicable E47: Drawing the line - the writing, reach, and limits of guidelines
|
Feb 22, 2026 |
|
Communicable E46: Steroids for pneumocystis pneumonia
|
Feb 08, 2026 |
|
Communicable E45: Top infectious diseases papers in 2025
|
Jan 25, 2026 |
|
Communicable E44: Top clinical microbiology papers in 2025
|
Jan 11, 2026 |
|
Communicable E43: Katie's picks
|
Dec 28, 2025 |
|
Communicable E42: Should doctors stay at X (Twitter) or leave it?
|
Dec 14, 2025 |
|
Communicable E41: Diagnostic stewardship
|
Nov 30, 2025 |
|
Communicable E40: AMR in conflict and crisis zones
|
Nov 16, 2025 |
|
Communicable E39: Dengue on the rise
|
Nov 02, 2025 |
|
Communicable E38: Why do you have to be so complicated? The 2025 IDSA Complicated UTI Guidelines
|
Oct 19, 2025 |
|
Communicable E37: 'Peer review is broken'
|
Oct 05, 2025 |
|
Communicable E36: Finding BALANCE in antibiotic durations—the BALANCE trial
|
Sep 19, 2025 |
|
Communicable E35: From Ebola to COVID-19 — Graham and Kobinger on building vaccines
|
Sep 07, 2025 |
|
Communicable E34: WHO's Fungal Priority Pathogens List
|
Aug 24, 2025 |
|
Communicable E33: Ethics in infectious diseases
|
Aug 10, 2025 |
|
Communicable E32: Fluoroquinolones - to heal or harm?
|
Jul 27, 2025 |
|
Communicable E31: Climate change and fungal spread
|
Jul 13, 2025 |
|
Communicable E30: WHO's first-ever guideline on meningitis
|
Jun 29, 2025 |
|
Communicable E29: Bacterial vaginosis & male partners
|
Jun 15, 2025 |
|
Communicable E28: Late-breaker trials at ESCMID Global: Should they change your practice? - part 2
|
Jun 01, 2025 |
|
Communicable E27: Late-breaker trials at ESCMID Global: Should they change your practice? - part 1
|
May 18, 2025 |
|
Communicable E26: SNAP out of it: Rethinking anti-staphylococcal penicillins for S. aureus bacteremia - the SNAP trial PSSA/MSSA results
|
May 04, 2025 |
|
Communicable E25: The Nightmare Series, part 5 - Measles is back
|
Apr 20, 2025 |
|
Communicable E24: The role of medical societies in global health - An interview with ESCMID leadership
|
Apr 06, 2025 |
|
Communicable E23: Women & men in medicine: An honest discussion, part 2
|
Mar 23, 2025 |
|
Communicable E22: Women & men in medicine: An honest discussion, part 1
|
Mar 07, 2025 |
|
Communicable E21: FMT for C. difficile infections - does it work?
|
Feb 23, 2025 |
|
Communicable E20: Tuberculosis today
|
Feb 09, 2025 |
|
Communicable E19: ‘Super gonorrhoea’ & other sexually transmitted infections
|
Jan 26, 2025 |
|
Communicable E18: The Nightmare Series, part 4 - How to manage polio and rubella
|
Jan 12, 2025 |
|
Communicable E17: Season’s greetings from the editors & holiday replay of late-breaker clinical trials at ESCMID Global 2024
|
Dec 29, 2024 |
|
Communicable E16: Climate change and infections – effects on clinical practice & sustainability
|
Dec 15, 2024 |
|
Communicable E15: Wastewater surveillance – can it really protect us from infections?
|
Dec 01, 2024 |
|
Communicable E14 - Substandard and falsified antimicrobials: what is their effect on patients and on AMR?
|
Nov 18, 2024 |
|
Communicable E13 - The Wild West of publishing today: predatory journals and how to deal with them
|
Nov 04, 2024 |
|
Communicable E12 - The Nightmare Series, part 3: How to deal with vancomycin-resistant enterococci
|
Oct 21, 2024 |
|
Communicable E11 - Nightmare series, part 2: How to deal with carbapenemase producers
|
Oct 07, 2024 |
|
Communicable E10 - Pipeline update: new antibiotics & other antimicrobials that you might actually use
|
Sep 23, 2024 |
|
Communicable E9 - Avian flu: an update
|
Sep 09, 2024 |
|
Communicable E8 - The Nightmare Series, part 1: How to deal with Candida auris
|
Aug 26, 2024 |
|
Communicable E7 - Melioidosis goes global
|
Aug 12, 2024 |
|
Communicable E6 - “Sneaky viruses”: an update on hepatitis B & C before World Hepatitis Day
|
Jul 25, 2024 |
|
Communicable E5 - Beauty is in the 'I' of the beholder: EUCAST updates
|
Jul 15, 2024 |
|
Communicable E4 - The BLING-3 trial & continuous beta-lactam infusion: should these results change your practice?
|
Jul 01, 2024 |
|
Communicable E3 - The new WHO Priority Pathogens List: which bugs to target first?
|
Jun 17, 2024 |
|
Communicable E2 - Phage therapy: does it work and will we have access?
|
Jun 03, 2024 |
|
Communicable E1 - Late-breaker clinical trial results from ESCMID Global 2024: Should they change your practice?
|
May 10, 2024 |